No products in the cart.
Lusutrombopag Tablets 3?mg (Wenke’da / MULPLETA) – Low price wholesale
$1.00
Wenke’da Lusutrombopag Tablets (MULPLETA), 3?mg per tablet, 7 tablets per blister, 1 blister per box. Produced by Quotient Sciences-Philadelphia LLC and NMPA approved under HJ20230086. Suitable for research on thrombocytopenia, platelet production, and TPO?RA mechanisms.
?? For laboratory and research use only. Not for clinical treatment.?Please consult staff for other specifications and uses?
Description
Lusutrombopag is an orally active thrombopoietin receptor agonist (TPO?RA) that stimulates platelet production, addressing thrombocytopenia associated with chronic liver disease before invasive procedures. Its compact 3?mg tablet form supports precise dosing in preclinical studies of platelet recovery and hemostasis.
Lusutrombopag Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Lusutrombopag Tablets (Wenke’da / MULPLETA) |
| Active Ingredient | Lusutrombopag |
| CAS Number | 1110766?97?6 |
| Molecular Formula | C??H??Cl?N?O?S |
| Strength | 3?mg per tablet |
| Pack Size | 7 tablets per blister (1 blister/box) |
| Dosage Form | Film-coated oral tablet |
| Approval Number | HJ20230086 (China NMPA) |
| Drug Standard Code | 86984813000016 |
| Manufacturer | Quotient Sciences?Philadelphia LLC, marketed by Shionogi |
| Barcode | Not yet assigned |
| Storage Conditions | Store below 25?°C, protected from moisture and light |
| Intended Use | Laboratory and preclinical research use |
Lusutrombopag Tablets Mechanism of Action
Lusutrombopag acts as a thrombopoietin receptor agonist, binding to the receptor on megakaryocyte precursors and stimulating platelet production. It increases platelet counts in thrombocytopenia associated with chronic liver disease.
Research Applications
Thrombocytopenia in chronic liver disease before invasive procedures
Pharmacodynamics of platelet recovery and hemostasis
Safety and efficacy profiling in preclinical models
Comparative studies with other TPO?RAs
Safety & Handling
Handling: Use PPE (gloves, lab coat, goggles); do not ingest outside experimental context.
Storage: Keep sealed and store below 25?°C.
Precautions: Not for human or veterinary use; follow lab protocols.
Core Keywords
lusutrombopag tablets, MULPLETA 3mg, CAS 1110766-97-6, HJ20230086, thrombopoietin receptor agonist, thrombocytopenia research, CLD platelet stimulant, wholesale lusutrombopag
Research Use Disclaimer
This product is strictly for laboratory and preclinical research use. It is not approved for clinical, therapeutic, or diagnostic use. Misuse may pose legal or health risks. Use only under institutional oversight and approved protocols.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 26 × 23 × 26 cm |
1 review for Lusutrombopag Tablets 3?mg (Wenke’da / MULPLETA) – Low price wholesale
Related products
Compound L?Aspartate L?Ornithine Granules 3?g (Rigan) – Wholesale & Research Use
Rigan Compound L?Aspartate L?Ornithine Granules provide 3?g per sachet, with 21 sachets per box. Manufactured by Wuhan Qirui Pharmaceutical Co., Ltd., and approved under NMPA H20090160. Designed for research into hyperammonemia, liver support, and metabolic detoxification.
?? For laboratory or research use only. ?Please consult staff for other specifications and uses? $1.00Pradefovir Mesylate Tablets 45?mg (Xinshumu)
Xinshumu Pradefovir Mesylate Tablets deliver 45?mg of pradefovir per tablet in a 30-tablet bottle. Manufactured by Xi’an Gelan Xintong Pharmaceutical Co., Ltd., with NMPA approval H20240036. Designed for preclinical and laboratory research on hepatitis B viral suppression and liver-targeted antiviral therapy.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $1.00Entecavir Dispersible Tablets 0.5?mg (Aipuding ) – Wholesale & Retail
Entecavir Dispersible Tablets (Aipuding / ???) deliver 0.5?mg entecavir per tablet in a fast?dissolving oral format, with 28 tablets per box. Manufactured by Hunan Qianjin Xieli Pharmaceutical Co., Ltd. (NMPA H20140093), this antiviral agent is extensively used in chronic hepatitis B research and clinical studies.?? For research and clinical use only.?Please consult staff for other specifications and uses? $2.00Drotaverine Hydrochloride Injection 40?mg (No?Spa )
No?Spa Drotaverine Hydrochloride Injection delivers 40?mg per 2?ml ampoule, with five ampoules per box. Produced by CHINOIN (Hungary) and approved under NMPA HJ20170302. Ideal for laboratory research involving smooth muscle spasm relief in visceral organs and vascular systems.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $1.00
felix –
Buon servizio, buon imballaggio, grazie